Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

47.24
Delayed Data
As of Jun 29
 +0.82 / +1.77%
Today’s Change
37.73
Today|||52-Week Range
50.39
-1.42%
Year-to-Date
ZTS Regular Dividend: ZTS began trading ex-dividend on 06/28/16. A $0.095 dividend will be paid to shareholders of record as of 06/30/16.
Steve Cohen's London Expansion Unfazed by Brexit Vote
Jun 28 / TheStreet.com - Paid Partner Content
Can Zoetis (ZTS) Keep the Earnings Streak Alive This Quarter?
Jun 17 / Zacks.com - Paid Partner Content
7 Profitable Medical Stocks Ranked as Buys Now
Jun 21 / Zacks.com - Paid Partner Content
5 Top ROE Stocks for Improving Your Portfolio Returns
Jun 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close46.42
Today’s open46.88
Day’s range46.68 - 47.38
Volume3,603,850
Average volume (3 months)3,977,510
Market cap$23.0B
Dividend yield0.80%
Data as of 4:01pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+5.56%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)-0.42%
P/E ratio62.6
Price/Sales5.05
Price/Book21.62

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.40+0.93%
VRTXVertex Pharmaceutica...+1.56+1.87%
ALXNAlexion Pharmaceutic...-0.77-0.67%
INCYIncyte Corp+2.16+2.81%
Data as of 4:00pm ET, 06/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.44
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts

Partner Offers

Search for Jobs